Upregulation of hepatic 11β-hydroxysteroid dehydrogenase-1 expression in calcium-deficient rats

Annals of Nutrition and Metabolism

Volumn 59, Issue 2-4, 2011, Pages 73-78

  Takaya, Junji ^a   Iharada, Anna ^a   Okihana, Hiroyuki ^a   Kaneko, Kazunari ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Glucocorticoid; mRNA; Phosphoenolpyruvate carboxykinase

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ADIPONECTIN; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN I 125; LEPTIN; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANALYZER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM DEFICIENCY; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICOSTEROID METABOLISM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; INSULIN RESISTANCE; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CALCIUM; CORTICOSTERONE; DIET; FEMALE; INSULIN; ION-SELECTIVE ELECTRODES; LEPTIN; LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION;

RATTUS; RATTUS NORVEGICUS;

EID: 82655179102     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000332915     Document Type: Article

References (32)

1. Schrager S: Dietary calcium intake and obesity. J Am Board Fam Pract 2005; 18: 205-210.
2. Pikilidou MI, Lasaridis AN, Sarafidis PA, et al: Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with type 2 diabetes. Diabet Med 2009; 26: 211-219.
3. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S: Calcium intake and body weight. J Clin Endocrinol Metab 2000; 85: 4635-4638.
4. McCarton DA, Reusser ME: Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 1999; 18(suppl 5):398S-405S.
5. Sen Y, Aygun D, Yilmaz E, Ayar A: Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels. Neuro Endocrinol Lett 2008; 29: 141-145.
6. Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P: Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 2005; 13: 1157-1166.
7. Weigensberg MJ, Toledo-Corral CM, Goran MI: Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab 2008; 93: 1372-1378.
8. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis D: The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
9. Walker BR: Cortisol -cause and cure for metabolic syndrome? Diabet Med 2006; 23: 1281-1288.
10. Cooper MS, Stewart PM: 11 β -Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-Adrenal axis, metabolic syndrome, and inflammation. J Clin Endocrinol Metab 2009; 94: 4645-4654.
11. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM: 11 β -Hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831-866.
12. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS: Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83-90.
13. Morton NM, Seckl JR: 11Beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res 2008; 36: 146-164.
14. Draper N, Stewart PM: 11 β -Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 2005; 186: 251-271.
15. Hanson RW, Patel YM: Phosphoenolpyruvate carboxykinase (GTP) gene. Adv Enzymol Relat Areas Mol Biol 1994; 69: 203-281.
16. Quinn PG, Yeagley D: Insulin regulation of PEPCK gene expression: A model for rapid and reversible modulation. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 423-437.
17. Reeves PG: Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997; 127: 838S-841S.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
19. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 18:RESEARCH0034.
20. London E, Castronouay TW: High fructose diets increase 11 β -hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity (Silver Spring) 2011; 19: 925-932.
21. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR: Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421.
22. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH: Cortisol metabolism in human obesity: Impared cortisone ] cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999; 84: 1022-1027.
23. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH, Stewart PM, Kumar S: 11 β -Hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 4755-4761.
24. Macfarlane DP, Forbes S, Walker BR: Glucocorticoids and fatty acid metabolism in humans: Fueling fat redistribution in the metabolic syndrome. J Endocrinol 2007; 197: 189-204.
25. Boucher BJ: Vitamin D insufficiency and diabetes risks. Curr Drug Targets 2011; 12: 61-87.
26. Shi H, DiRienzo D, Zemel MB: Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-Agouti transgenic mice. FASEB J 2001; 15: 291-293.
27. Bouvard B, Annweiler C, Salle A, Beauchet O, Chappard D, Audran M, Legrand E: Extraskeletal effects of vitamin D: Facts, uncertainties, and controversies. Joint Bone Spine 2011; 78: 10-16.
28. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104: 342-345.
29. Jobgen WS, Fried SK, Fu WJ, Meninger CJ, Wu G: Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 2006; 17: 571-588.
30. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-Aged and older US women. Diabetes Care 2005; 28: 2926-2932.
31. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
32. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS: Dairy consumption, obesity, and the insulin resistance syndrome in young adults: The CARDIA Study. JAMA 2002; 287: 2081-2089.